Global Sickle Cell Anemia Testing Market to Reach $503M by 2032 with 6% CAGR: WHO Estimates 230,000 Infants Born with Sickle Cell in Sub-Saharan Africa Each Year

The sickle cell anemia testing and screening market is expected to witness a revenue CAGR of 6% during the forecast period, reaching USD 503.04 million in 2032 from USD 297.75 million in 2022. The market growth is primarily driven by the increasing prevalence of sickle cell anemia, particularly in regions such as Africa, the Middle East, and India. Molecular genetic testing, hemoglobin electrophoresis, and newborn screening are some of the advanced techniques that aid in precise and early identification of the disease, leading to prompt therapy and symptom control.

The growing awareness of sickle cell anemia and its symptoms, particularly among high-risk groups, is further contributing to the demand for testing and screening services in healthcare facilities. The market revenue growth is also supported by governments and healthcare institutions that are placing greater emphasis on disease management and prevention. However, the lack of infrastructure and knowledge in certain areas, high cost of testing and screening services, and limited treatment options remain major hindrances to market growth.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/6414

Key players in the Sickle Cell Anemia Testing and Screening Market -

• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Siemens AG
• Thermo Fisher Scientific Inc.
• PerkinElmer, Inc.
• BioMedomics, Inc.
• Pointe Scientific, Inc.
• TCS Biosciences Ltd.

Segments Covered in the Report

The market for testing and screening services is expected to experience significant growth over the next decade. This growth is driven by the increasing demand for early disease detection and prevention. The market is segmented by test type and end-use.

In terms of test type, the market is segmented into blood test, DNA test, and newborn screening. Blood tests are a commonly used diagnostic tool that measures different components of blood to identify health issues. DNA tests analyze a patient's DNA for genetic variations that may lead to the development of certain conditions. Newborn screening involves testing newborn babies for a range of conditions, including sickle cell anemia, to enable early detection and treatment.

In terms of end-use, the market is segmented into hospitals and clinics, diagnostic laboratories, and home care. Hospitals and clinics are the largest end-users of testing and screening services, as they provide a wide range of medical services, including diagnostic tests. Diagnostic laboratories are specialized facilities that focus on testing and analysis. Home care involves the provision of medical services to patients in their own homes, which can include diagnostic testing and screening.

The growth of the testing and screening market is also driven by technological advancements in the field of medical testing. The development of new and improved testing methods, such as molecular genetic testing and hemoglobin electrophoresis, has facilitated more accurate and early detection of diseases, enabling prompt therapy and symptom control. These technological advancements have increased the demand for testing and screening services in hospitals, clinics, and diagnostic laboratories.

However, there are several factors that are hindering market revenue growth. These include a lack of infrastructure and knowledge in certain areas, high cost of testing and screening services, and scarcity of treatment options. Governments and healthcare institutions are working to address these issues by increasing awareness and investing in the management and prevention of diseases. Additionally, the establishment of newborn screening programs in several countries has helped to detect and treat diseases in infants, which can significantly improve health outcomes.

Access Full Report Description with Research Methodology and Table of Contents @ https://www.reportsanddata.com/report-detail/sickle-cell-anemia-testing-and-screening-market

Strategic development:

Several companies made significant moves in the field of sickle cell anemia in recent years. In 2021, Abbott Laboratories partnered with the Sickle Cell Disease Association of America (SCDAA) to launch a new program in the United States aimed at improving sickle cell disease care. The program is designed to support patients, caregivers, and healthcare providers in improving the diagnosis and management of the disease.

Bio-Rad Laboratories, Inc. acquired Celsee, Inc. in 2020 to expand its product offerings in the single-cell analysis market. This acquisition has applications in sickle cell anemia research. In the same year, Thermo Fisher Scientific Inc. announced a collaboration with Biognosys AG to develop a mass spectrometry-based assay for the detection and quantification of hemoglobin variants, including those associated with sickle cell anemia.

Danaher Corporation's subsidiary, Beckman Coulter, launched the DxH 690T hematology analyzer in 2021, which can provide accurate and reliable results for sickle cell disease testing. The analyzer uses advanced technology to offer a complete blood count and hemoglobinopathy analysis in a single test.

In 2020, F. Hoffmann-La Roche AG launched the Elecsys® Anti-SARS-CoV-2 S antibody test to detect antibodies against the SARS-CoV-2 virus in human blood. While this test is not specific to sickle cell anemia, it has applications in the screening and diagnosis of sickle cell patients, who can be at higher risk of COVID-19 complications.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6414

Read More About: -

Cryptococcosis Market - https://www.reportsanddata.com/report-detail/cryptococcosis-market

Antidiuretic Drugs Market - https://www.reportsanddata.com/report-detail/antidiuretic-drugs-market

Dental Turbines Market - https://www.reportsanddata.com/report-detail/dental-turbines-market

Life Sciences Software Market - https://www.reportsanddata.com/report-detail/life-sciences-software-market

Canine Influenza Vaccine Market - https://www.reportsanddata.com/report-detail/canine-influenza-vaccine-market

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs

This release was published on openPR.